Many women in perimenopause and menopause notice real changes: vaginal dryness, irritation, pain during intimacy, reduced sensation, and a drop in desire that feels frustrating and isolating. These shifts are driven by hormonal changes and are extremely common. They are also highly treatable.
You do not have to accept discomfort or a loss of intimacy as inevitable. Targeted, evidence-based approaches can restore tissue health, ease pain, support desire, and help you feel more like yourself.
As estrogen declines, the tissues of the vagina, vulva, and surrounding areas become thinner, less elastic, and drier. This is known as genitourinary syndrome of menopause (GSM). It commonly causes dryness, burning, itching, and painful intercourse. At the same time, changes in hormones and brain chemistry can lower spontaneous and responsive desire (sometimes diagnosed as hypoactive sexual desire disorder, or HSDD).
These issues affect daily comfort, relationships, and overall well-being. Addressing them is an important part of midlife health.
Regular, comfortable sexual activity is linked in observational research to better markers of cardiovascular health, lower inflammation, and higher quality of life. While it is not a proven way to extend lifespan, maintaining sexual function supports physical comfort, emotional connection, and a sense of vitality—priorities that matter deeply during the perimenopause and menopause transition. Many clinicians who focus on healthy aging view sexual health as one meaningful indicator of overall wellness.
Simple daily habits support every other treatment:
These steps help many women with mild symptoms and create a better foundation for medical treatments when needed.
Vaginal moisturizers (used regularly) and personal lubricants (used during intimacy) are effective first steps for dryness and discomfort. Pelvic floor physical therapy and vaginal dilators can also help when tightness or muscle guarding contributes to pain. These options are widely available and appropriate for most women.
For moderate to severe symptoms of GSM, several prescription options have strong evidence:
Local vaginal estrogen (cream, tablet, insert, or low-dose ring) restores moisture, elasticity, and tissue health with minimal systemic absorption. Options include estradiol cream, vaginal tablets or inserts, and the Estring ring.
Prasterone (Intrarosa) is a vaginal DHEA insert that works locally to improve tissue health and reduce painful intercourse.
Ospemifene (Osphena) is an oral medication taken daily that acts on vaginal tissue to ease dryness and pain with sex.
These treatments are among the most effective and well-studied approaches for vaginal symptoms of menopause. Many women notice meaningful improvement within weeks.
When hot flashes, night sweats, sleep disruption, or other systemic symptoms are also present, menopausal hormone therapy (estrogen, with progestogen if needed) can improve overall well-being and often helps vaginal symptoms at the same time. It is FDA-approved for moderate to severe menopausal symptoms and for prevention of bone loss in appropriate candidates.
When low desire causes personal distress and is not explained by other factors, additional approaches may help:
Some women explore the O-Shot, an in-office procedure that uses platelet-rich plasma (PRP) prepared from a small sample of their own blood and injected into clitoral and vaginal tissues. The goal is to support local blood flow, sensation, and tissue comfort. This use of PRP is not FDA-approved for sexual health or GSM. Results vary, evidence is limited to smaller studies and clinical experience, and it is offered as an elective complementary option after a full evaluation and informed consent. Standard injection risks apply.
Learn more about PRP injections at Rofé Medical.
Most women do best with a combination tailored to their symptoms, medical history, and goals. This may include non-hormonal care, local FDA-approved treatments for tissue health, systemic hormone therapy when appropriate, desire-specific medications, pelvic floor support, and carefully considered regenerative options.
We start with a thorough conversation and evaluation so your plan fits your body and priorities.
How quickly do local treatments work?
Many women notice improved comfort within a few weeks of consistent use.
Can these treatments be used together?
Yes. Local therapies, systemic hormones, lubricants, and other approaches are often combined.
Is the O-Shot right for everyone?
It is an elective option with variable results and is not FDA-approved for these uses. We discuss suitability individually.
Sexual health is part of overall well-being in midlife. If dryness, pain, or low desire are affecting you, effective options are available.
This page is for educational purposes only and does not constitute medical advice or create a patient-provider relationship. Treatments and suitability depend on individual medical history and should be discussed with a qualified healthcare provider. FDA-approved medications are discussed according to their approved indications. The O-Shot and similar PRP procedures are not FDA-approved for the treatment of sexual dysfunction, vaginal dryness, or genitourinary syndrome of menopause; they are elective, results vary, and no specific outcomes are guaranteed. Observational links between sexual activity and health markers do not establish that any treatment extends lifespan. Individual results vary.
Meet Our Team
